Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02101099
Other study ID # CFM-04
Secondary ID 5R44DK068936
Status Completed
Phase N/A
First received March 28, 2014
Last updated July 11, 2016
Start date March 2014
Est. completion date December 2015

Study information

Verified date July 2016
Source Artann Laboratories
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Observational

Clinical Trial Summary

The aim of the study is to determine if more force is used during colonoscopy when patients receive monitored anesthesia with propofol versus conscious sedation. Force measurements will be performed using the colonoscopy force monitor (CFM). This device measures the magnitude and direction of force applied to the insertion tube of a standard colonoscope during colonoscopy.


Description:

Randomized factorial design of colonoscopy with either propofol administered anesthesia or conscious sedation. Twelve experienced endoscopists from community and academic centers will perform colonoscopy using either propofol or conscious sedation on a group of 12 patients for each endoscopist for a study total of 144 patients. An equal number of male and female patients will be included in each group.


Recruitment information / eligibility

Status Completed
Enrollment 102
Est. completion date December 2015
Est. primary completion date December 2015
Accepts healthy volunteers No
Gender Both
Age group 30 Years to 75 Years
Eligibility Inclusion Criteria:

- Male or female

- Age: 30-75 years

- ASA Class I or II

- All ethnic and racial groups will be included

Exclusion Criteria:

- Colonic pathology that in the opinion of the endoscopist could interfere with the colonoscopy. Examples include: colonic stricture, poor preparation, obstructing tumor.

- Specific pathology that would limit the extent of examination

- ASA class 3 or greater

- Pregnancy

- Monitored anesthesia using propofol for sedation.

- Vulnerable subjects. Students, nursing home residents, institutionalized patients, and those with psychological or physical incapacity

Study Design

Observational Model: Case-Only, Time Perspective: Prospective


Related Conditions & MeSH terms


Intervention

Device:
Colonoscopy Force Monitor
Use of Colonoscopy Force Monitoring device (CFM) to measure forces applied to the colonoscope during the procedure.

Locations

Country Name City State
United States Chevy Chase Endoscopy Center Chevy Chase Maryland
United States Univeristy of Pennsylvania Medical Center Philadelphia Pennsylvania
United States Georgetown University Medical Center, Gastroenterology Washington District of Columbia

Sponsors (5)

Lead Sponsor Collaborator
Artann Laboratories Capital Digestive Care, LLC, Georgetown University, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), University of Pennsylvania

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Peak push force is increased in patients receiving propofol as compared to conscious sedation. 6 months Yes